Molecular testing of EGFR and ALK in lung adenocarcinoma is recommended by the guidelines from College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology[6]. This evidence concerns the gene ALK and lung adenocarcinoma.